Ameriprise
WGS icon

Ameriprise’s GeneDx Holdings WGS Stock Holding History

Ameriprise’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.3M Buy
207,664
+11,775
+6% +$669K ﹤0.01% 1780
2026
Q1 		$12.6M Buy
195,889
+78,832
+67% +$7.19M ﹤0.01% 1754
2025
Q4 		$15.2M Sell
117,057
-66,010
-36% -$9.06M ﹤0.01% 1610
2025
Q3 		$19.7M Sell
183,067
-72,864
-28% -$7.94M ﹤0.01% 1411
2025
Q2 		$23.6M Buy
255,931
+110,684
+76% +$8.69M 0.01% 1248
2025
Q1 		$12.9M Buy
145,247
+110,840
+322% +$9.62M ﹤0.01% 1582
2024
Q4 		$2.64M Buy
+34,407
New +$2.4M ﹤0.01% 2767
2021
Q4 		– Sell
-23,028
Closed -$5.77M – 4052
2021
Q3 		$5.77M Buy
23,028
+117
+0.5% +$40.2K ﹤0.01% 2291
2021
Q2 		$10.6M Buy
22,911
+4,980
+28% +$2.14M ﹤0.01% 1897
2021
Q1 		$8.81M Buy
+17,931
New +$9.32M ﹤0.01% 1986

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Ameriprise's WGS Position: Q2 2026 in Review

Ameriprise increased its GeneDx Holdings (WGS) stake by 6% in Q2 2026, buying an estimated $669K and bringing the position to 207,664 shares worth $14.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1780.

Ameriprise first reported a position in WGS in Q1 2021 and has held it in 10 quarters since. The position peaked at $23.6M in Q2 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Ameriprise held 207,664 shares of GeneDx Holdings worth $14.3M as of Q2 2026.
  • Ameriprise bought 11,775 GeneDx Holdings shares in Q2 2026, an estimated $669K.
  • GeneDx Holdings made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #1780 holding.
  • Ameriprise first reported a position in GeneDx Holdings in Q1 2021 and has held it in 10 quarters since.
  • Ameriprise's GeneDx Holdings position peaked at $23.6M in Q2 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.